Medicine

Roche acquires mySugr to form a leading open platform for digital diabetes management

Election of a New Chairman of the Board of Directors of SHL Telemedicine

Novartis real world study shows almost half of chronic urticaria patients are not receiving any treatment despite significant disease burden

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG.

Sandoz receives approval in Europe for Rixathon® (biosimilar rituximab) to treat blood cancers and immunological diseases

Kuros Biosciences launches rights and share offering

Bristol-Myers Squibb Company (NYSE:BMY) and SK Biotek Co., Ltd. today announced the companies have signed a definitive purchase agreement to sell Bristol-Myers Squibb’s small molecule active pharmaceutical ingredient manufacturing facility in Swords, Ireland, to SK Biotek

Accenture and quantum software firm 1QBit collaborated with Biogen to develop a first-of-its-kind quantum-enabled molecular comparison application that could significantly improve advanced molecular design to speed up drug discovery for complex neurological conditions

Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility

Basilea awarded USD 54.8 million of additional funding by BARDA to support phase 3 development of ceftobiprole

Astellas today announced data from an exploratory analysis of the Phase I/II CHRYSALIS study, which demonstrated that FLT3 mutation-positive relapsed/refractory (R/R) AML patients with molecular response had improved OS compared with those without a molecular response

Novartis drug Tasigna receives EU approval for inclusion of Treatment-free Remission (TFR) data in product label

Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the signing of an agreement granting the exclusive right to market NATESTO^® in Saudi Arabia, the United Arab Emirates and Egypt to Therios Healthcare

IBM today announced that Baheal Pharmaceutical Group is extending the reach of Watson for Oncology to clinicians across China through a new multi-year strategic alliance.